 | • レポートコード：GIR-105X14309 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、レゴラフェニブのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。レゴラフェニブの種類別市場規模（ボトル包装、フィルムコーティング包装）、用途別市場規模（転移性結腸直腸癌、進行性消化管間質腫瘍、進行性肝細胞癌、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・レゴラフェニブの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bayer Pharmaceuticals、Beacon Pharmaceuticals、Drug International ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ボトル包装、フィルムコーティング包装 ・用途別分析2016年-2026年：転移性結腸直腸癌、進行性消化管間質腫瘍、進行性肝細胞癌、その他 ・レゴラフェニブの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・レゴラフェニブのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・レゴラフェニブのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・レゴラフェニブの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・レゴラフェニブの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Regorafenib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Regorafenib size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Regorafenib market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Regorafenib market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Bottled Packaging
Film Coated Packaging
Market segment by Application can be divided into
Metastatic Colorectal Cancer
Advanced Gastrointestinal Stromal Tumours
Advanced Hepatocellular Carcinoma
Other
The key market players for global Regorafenib market are listed below:
Bayer Pharmaceuticals
Beacon Pharmaceuticals
Drug International
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Regorafenib Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Regorafenib Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Bottled Packaging
1.2.3 Film Coated Packaging
1.3 Market Analysis by Application
1.3.1 Overview: Global Regorafenib Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Metastatic Colorectal Cancer
1.3.3 Advanced Gastrointestinal Stromal Tumours
1.3.4 Advanced Hepatocellular Carcinoma
1.3.5 Other
1.4 Global Regorafenib Market Size & Forecast
1.4.1 Global Regorafenib Sales in Value (2016-2026))
1.4.2 Global Regorafenib Sales in Volume (2016-2026)
1.4.3 Global Regorafenib Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Regorafenib Production Capacity Analysis
1.5.1 Global Regorafenib Total Production Capacity (2016-2026)
1.5.2 Global Regorafenib Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Regorafenib Market Drivers
1.6.2 Regorafenib Market Restraints
1.6.3 Regorafenib Trends Analysis
2 Manufacturers Profiles
2.1 Bayer Pharmaceuticals
2.1.1 Bayer Pharmaceuticals Details
2.1.2 Bayer Pharmaceuticals Major Business
2.1.3 Bayer Pharmaceuticals Regorafenib Product and Services
2.1.4 Bayer Pharmaceuticals Regorafenib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Beacon Pharmaceuticals
2.2.1 Beacon Pharmaceuticals Details
2.2.2 Beacon Pharmaceuticals Major Business
2.2.3 Beacon Pharmaceuticals Regorafenib Product and Services
2.2.4 Beacon Pharmaceuticals Regorafenib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Drug International
2.3.1 Drug International Details
2.3.2 Drug International Major Business
2.3.3 Drug International Regorafenib Product and Services
2.3.4 Drug International Regorafenib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Regorafenib Sales by Manufacturer
3.1 Global Regorafenib Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Regorafenib Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Regorafenib
3.4 Market Concentration Rate
3.4.1 Top 3 Regorafenib Manufacturer Market Share
3.4.2 Top 6 Regorafenib Manufacturer Market Share
3.5 Global Regorafenib Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Regorafenib Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Regorafenib Market Size by Region
4.1.1 Global Regorafenib Sales in Volume by Region (2016-2026)
4.1.2 Global Regorafenib Revenue by Region (2016-2026)
4.2 North America Regorafenib Revenue (2016-2026)
4.3 Europe Regorafenib Revenue (2016-2026)
4.4 Asia-Pacific Regorafenib Revenue (2016-2026)
4.5 South America Regorafenib Revenue (2016-2026)
4.6 Middle East and Africa Regorafenib Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Regorafenib Sales in Volume by Type (2016-2026)
5.2 Global Regorafenib Revenue by Type (2016-2026)
5.3 Global Regorafenib Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Regorafenib Sales in Volume by Application (2016-2026)
6.2 Global Regorafenib Revenue by Application (2016-2026)
6.3 Global Regorafenib Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Regorafenib Sales by Type (2016-2026)
7.2 North America Regorafenib Sales by Application (2016-2026)
7.3 North America Regorafenib Market Size by Country
7.3.1 North America Regorafenib Sales in Volume by Country (2016-2026)
7.3.2 North America Regorafenib Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Regorafenib Sales by Type (2016-2026)
8.2 Europe Regorafenib Sales by Application (2016-2026)
8.3 Europe Regorafenib Market Size by Country
8.3.1 Europe Regorafenib Sales in Volume by Country (2016-2026)
8.3.2 Europe Regorafenib Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Regorafenib Sales by Type (2016-2026)
9.2 Asia-Pacific Regorafenib Sales by Application (2016-2026)
9.3 Asia-Pacific Regorafenib Market Size by Region
9.3.1 Asia-Pacific Regorafenib Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Regorafenib Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Regorafenib Sales by Type (2016-2026)
10.2 South America Regorafenib Sales by Application (2016-2026)
10.3 South America Regorafenib Market Size by Country
10.3.1 South America Regorafenib Sales in Volume by Country (2016-2026)
10.3.2 South America Regorafenib Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Regorafenib Sales by Type (2016-2026)
11.2 Middle East & Africa Regorafenib Sales by Application (2016-2026)
11.3 Middle East & Africa Regorafenib Market Size by Country
11.3.1 Middle East & Africa Regorafenib Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Regorafenib Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Regorafenib Typical Distributors
12.3 Regorafenib Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Regorafenib Revenue by Type, (USD Million), 2021-2026
Table 2. Global Regorafenib Revenue by Application, (USD Million), 2021-2026
Table 3. Bayer Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Pharmaceuticals Major Business
Table 5. Bayer Pharmaceuticals Regorafenib Product and Services
Table 6. Bayer Pharmaceuticals Regorafenib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Beacon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Beacon Pharmaceuticals Major Business
Table 9. Beacon Pharmaceuticals Regorafenib Product and Services
Table 10. Beacon Pharmaceuticals Regorafenib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Drug International Basic Information, Manufacturing Base and Competitors
Table 12. Drug International Major Business
Table 13. Drug International Regorafenib Product and Services
Table 14. Drug International Regorafenib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Global Regorafenib Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 16. Global Regorafenib Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 17. Market Position of Manufacturers in Regorafenib, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 18. Global Regorafenib Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 19. Head Office and Regorafenib Production Site of Key Manufacturer
Table 20. Global Regorafenib Sales by Region (2016-2021e) & (K Pcs)
Table 21. Global Regorafenib Sales by Region (2021-2026) & (K Pcs)
Table 22. Global Regorafenib Revenue by Region (2016-2021e) & (USD Million)
Table 23. Global Regorafenib Revenue by Region (2021-2026) & (USD Million)
Table 24. Global Regorafenib Sales by Type (2016-2021e) & (K Pcs)
Table 25. Global Regorafenib Sales by Type (2021-2026) & (K Pcs)
Table 26. Global Regorafenib Revenue by Type (2016-2021e) & (USD Million)
Table 27. Global Regorafenib Revenue by Type (2021-2026) & (USD Million)
Table 28. Global Regorafenib Price by Type (2016-2021e) & (USD/Pcs)
Table 29. Global Regorafenib Price by Type (2021-2026) & (USD/Pcs)
Table 30. Global Regorafenib Sales by Application (2016-2021e) & (K Pcs)
Table 31. Global Regorafenib Sales by Application (2021-2026) & (K Pcs)
Table 32. Global Regorafenib Revenue by Application (2016-2021e) & (USD Million)
Table 33. Global Regorafenib Revenue by Application (2021-2026) & (USD Million)
Table 34. Global Regorafenib Price by Application (2016-2021e) & (USD/Pcs)
Table 35. Global Regorafenib Price by Application (2021-2026) & (USD/Pcs)
Table 36. North America Regorafenib Sales by Country (2016-2021e) & (K Pcs)
Table 37. North America Regorafenib Sales by Country (2021-2026) & (K Pcs)
Table 38. North America Regorafenib Revenue by Country (2016-2021e) & (USD Million)
Table 39. North America Regorafenib Revenue by Country (2021-2026) & (USD Million)
Table 40. North America Regorafenib Sales by Type (2016-2021e) & (K Pcs)
Table 41. North America Regorafenib Sales by Type (2021-2026) & (K Pcs)
Table 42. North America Regorafenib Sales by Application (2016-2021e) & (K Pcs)
Table 43. North America Regorafenib Sales by Application (2021-2026) & (K Pcs)
Table 44. Europe Regorafenib Sales by Country (2016-2021e) & (K Pcs)
Table 45. Europe Regorafenib Sales by Country (2021-2026) & (K Pcs)
Table 46. Europe Regorafenib Revenue by Country (2016-2021e) & (USD Million)
Table 47. Europe Regorafenib Revenue by Country (2021-2026) & (USD Million)
Table 48. Europe Regorafenib Sales by Type (2016-2021e) & (K Pcs)
Table 49. Europe Regorafenib Sales by Type (2021-2026) & (K Pcs)
Table 50. Europe Regorafenib Sales by Application (2016-2021e) & (K Pcs)
Table 51. Europe Regorafenib Sales by Application (2021-2026) & (K Pcs)
Table 52. Asia-Pacific Regorafenib Sales by Region (2016-2021e) & (K Pcs)
Table 53. Asia-Pacific Regorafenib Sales by Region (2021-2026) & (K Pcs)
Table 54. Asia-Pacific Regorafenib Revenue by Region (2016-2021e) & (USD Million)
Table 55. Asia-Pacific Regorafenib Revenue by Region (2021-2026) & (USD Million)
Table 56. Asia-Pacific Regorafenib Sales by Type (2016-2021e) & (K Pcs)
Table 57. Asia-Pacific Regorafenib Sales by Type (2021-2026) & (K Pcs)
Table 58. Asia-Pacific Regorafenib Sales by Application (2016-2021e) & (K Pcs)
Table 59. Asia-Pacific Regorafenib Sales by Application (2021-2026) & (K Pcs)
Table 60. South America Regorafenib Sales by Country (2016-2021e) & (K Pcs)
Table 61. South America Regorafenib Sales by Country (2021-2026) & (K Pcs)
Table 62. South America Regorafenib Revenue by Country (2016-2021e) & (USD Million)
Table 63. South America Regorafenib Revenue by Country (2021-2026) & (USD Million)
Table 64. South America Regorafenib Sales by Type (2016-2021e) & (K Pcs)
Table 65. South America Regorafenib Sales by Type (2021-2026) & (K Pcs)
Table 66. South America Regorafenib Sales by Application (2016-2021e) & (K Pcs)
Table 67. South America Regorafenib Sales by Application (2021-2026) & (K Pcs)
Table 68. Middle East & Africa Regorafenib Sales by Country (2016-2021e) & (K Pcs)
Table 69. Middle East & Africa Regorafenib Sales by Country (2021-2026) & (K Pcs)
Table 70. Middle East & Africa Regorafenib Revenue by Country (2016-2021e) & (USD Million)
Table 71. Middle East & Africa Regorafenib Revenue by Country (2021-2026) & (USD Million)
Table 72. Middle East & Africa Regorafenib Sales by Type (2016-2021e) & (K Pcs)
Table 73. Middle East & Africa Regorafenib Sales by Type (2021-2026) & (K Pcs)
Table 74. Middle East & Africa Regorafenib Sales by Application (2016-2021e) & (K Pcs)
Table 75. Middle East & Africa Regorafenib Sales by Application (2021-2026) & (K Pcs)
Table 76. Direct Channel Pros & Cons
Table 77. Indirect Channel Pros & Cons
Table 78. Regorafenib Typical Distributors
Table 79. Regorafenib Typical Customers
List of Figures
Figure 1. Regorafenib Picture
Figure 2. Global Regorafenib Sales Market Share by Type in 2020
Figure 3. Bottled Packaging
Figure 4. Film Coated Packaging
Figure 5. Global Regorafenib Sales Market Share by Application in 2020
Figure 6. Metastatic Colorectal Cancer
Figure 7. Advanced Gastrointestinal Stromal Tumours
Figure 8. Advanced Hepatocellular Carcinoma
Figure 9. Other
Figure 10. Global Regorafenib Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 11. Global Regorafenib Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Regorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Regorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Regorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Regorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Regorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Regorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Regorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Regorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Regorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Regorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Regorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Regorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Regorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Regorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Regorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Regorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Regorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Regorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Regorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Regorafenib Sales (2016-2026) & (K Pcs)
Figure 32. Global Regorafenib Production Capacity (2016-2026) & (K Pcs)
Figure 33. Global Regorafenib Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Regorafenib Market Drivers
Figure 35. Regorafenib Market Restraints
Figure 36. Regorafenib Market Trends
Figure 37. Global Regorafenib Sales Market Share by Manufacturer in 2020
Figure 38. Global Regorafenib Revenue Market Share by Manufacturer in 2020
Figure 39. Regorafenib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Regorafenib Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Regorafenib Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Regorafenib Sales Market Share by Region (2016-2026)
Figure 43. Global Regorafenib Revenue Market Share by Region (2016-2026)
Figure 44. North America Regorafenib Revenue (2016-2026) & (USD Million)
Figure 45. Europe Regorafenib Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Regorafenib Revenue (2016-2026) & (USD Million)
Figure 47. South America Regorafenib Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Regorafenib Revenue (2016-2026) & (USD Million)
Figure 49. Global Regorafenib Sales Market Share by Type (2016-2026)
Figure 50. Global Regorafenib Revenue Market Share by Type (2016-2026)
Figure 51. Global Regorafenib Price by Type (2016-2026) & (USD/Pcs)
Figure 52. Global Regorafenib Sales Market Share by Application (2016-2026)
Figure 53. Global Regorafenib Revenue Market Share by Application (2016-2026)
Figure 54. Global Regorafenib Price by Application (2016-2026) & (USD/Pcs)
Figure 55. North America Regorafenib Sales Market Share by Country (2016-2026)
Figure 56. North America Regorafenib Revenue Market Share by Country (2016-2026)
Figure 57. North America Regorafenib Sales Market Share by Type (2016-2026)
Figure 58. North America Regorafenib Sales Market Share by Application (2016-2026)
Figure 59. Europe Regorafenib Sales Market Share by Country (2016-2026)
Figure 60. Europe Regorafenib Revenue Market Share by Country (2016-2026)
Figure 61. Europe Regorafenib Sales Market Share by Type (2016-2026)
Figure 62. Europe Regorafenib Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Regorafenib Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Regorafenib Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Regorafenib Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Regorafenib Sales Market Share by Application (2016-2026)
Figure 67. South America Regorafenib Sales Market Share by Country (2016-2026)
Figure 68. South America Regorafenib Revenue Market Share by Country (2016-2026)
Figure 69. South America Regorafenib Sales Market Share by Type (2016-2026)
Figure 70. South America Regorafenib Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Regorafenib Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Regorafenib Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Regorafenib Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Regorafenib Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
肝細胞がん治療薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 HCC is the most common form of primary liver cancer in adults and occurs mainly in the patients with underlying liver disease and cirrhosis. The disease originates in the liver unlike the secondary liver cancers which reaches to the liver from other organs of the body. Currently only two drugs NEXAV…- 世界の先進パッケージングシステム市場 2021：企業別、地域別、種類・用途別 The Advanced Packaging System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…
- インビトロ結腸直腸がんスクリーニング試験の世界市場予測 2023年：メーカー別、地域別、種類・用途別 In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer. Scope of the Report: This report studies the In-Vitro Colorectal Cancer Screening Tests market status and outlook of Global and major regions, from angles of players, countries, produc…
- 結腸直腸癌治療の世界市場2018-2025 Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). A cancer is the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Signs and symptoms may include bl…
- 世界のスーパーバリアコーティングフィルム市場 2021：企業別、地域別、種類・用途別 The Super Barrier Coated Film market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…